List Title | APhA DrugInfoLine

Focus on Diabetes Care

SORT BY: Most Recent Most Viewed

March 1, 2002

Acute Pancreatitis Linked to Obesity, Glyburide Therapy

READ

PREVIEW
A small study from Sweden identifies an increased risk of acute pancreatitis among patients who are obese or are taking the antidiabetic agent glyburide.
January 1, 2002

Updated Guidelines Address Hypertension, Nutrition, and Medical Care

READ

PREVIEW
In its annually updated guidelines for care of patients with or at risk for diabetes mellitus (DM), the American Diabetes Association (ADA) provides clinicians and patients with new information...
October 1, 2001

Renoprotection from Angiotensin Inhibition: Evidence, Diabetic Use Grow

READ

PREVIEW
Beneficial effects of angiotensin II receptor blockers (ARBs) in middle-aged and older patients with type 2 diabetes as demonstrated in three just-published studies confirm earlier evidence from...
August 1, 2001

Diabetes Meeting Features Wide Variety of Topics

READ

PREVIEW
Presenters at the 61st annual scientific sessions of the American Diabetes Association (ADA) emphasized several topics of interest to pharmacists specializing in diabetes care: obesity and...
June 1, 2001

ATP III Adds Millions of Americans to Treatment Categories

READ

PREVIEW
The first revision in 8 years to federal guidelines on hypercholesterolemia management uses a complex formula to calculate Americans’ risk for coronary heart disease (CHD) or CHD events. The net...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.